Proteomics

Dataset Information

0

Full proteome analysis of WT and Ezh2-KO K562 cells

ABSTRACT: Chemotherapy resistance is the main impediment in the treatment of acute myeloid leukaemia (AML). Despite rapid advances, the various mechanisms that lead to resistance development remain to be defined in detail. Here we report that loss-of-function mutations (LOF) in the histone methyltransferase EZH2 have the potential to confer resistance against the chemotherapeutic agent cytarabine. We identify seven distinct EZH2 mutations leading to loss of H3K27 trimethylation via multiple mechanisms. Analysis of matched diagnosis and relapse samples reveal a heterogenous regulation of EZH2 and a loss of EZH2 in 50% of patients. We confirm that loss of EZH2 induces resistance against cytarabine in the cell lines HEK293T and K562 as well as in a patient-derived xenograft (PDX) model. Proteomics and transcriptomics analysis reveal that resistance is conferred by upregulation of multiple direct and indirect EZH2 target genes that are involved in apoptosis evasion, augmentation of proliferation and alteration of transmembrane transporter function. Our data indicates, that loss of EZH2 results in upregulation of its target genes, providing the cell with a selective growth advantage, which mediates chemotherapy resistance.

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Homo Sapiens (human)

DISEASE(S): Acute Leukemia

SUBMITTER: Enes Ugur  

LAB HEAD: Heinrich Leonhardt

PROVIDER: PXD023139 | Pride | 2021-03-12

REPOSITORIES: Pride

Json Xml
altmetric image

Publications

Placentas can exhibit chromosomal aberrations that are absent from the fetus<sup>1</sup>. The basis of this genetic segregation, which is known as confined placental mosaicism, remains unknown. Here we investigated the phylogeny of human placental cells as reconstructed from somatic mutations, using whole-genome sequencing of 86 bulk placental samples (with a median weight of 28 mg) and of 106 microdissections of placental tissue. We found that every bulk placental sample represents a clonal exp  ...[more]

Similar Datasets

Transcriptomics Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
2021-03-12 | GSE162623 | GEO
Proteomics MS-based phosphoproteomic of cytarabine-treated FLT3-ITD cells
2023-07-20 | PXD038638 | Pride
Transcriptomics EZH2 deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress
2020-08-28 | GSE127261 | GEO
Genomics PRC2 Inactivation Induces Primary Chemoresistance by Repressing Mitochondrial Apoptosis in T-ALL
2018-10-18 | GSE112147 | GEO
Proteomics The regulatory roles of Ezh2 in response to lipopolysaccharide (LPS) in macrophages and mice with conditional Ezh2 deletion with LysM-Cre system
2023-07-20 | PXD041265 | Pride
Genomics EZH2 deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress
2020-05-31 | GSE147198 | GEO
Proteomics Circulating SOD2 is a Response Biomarker for Neoadjuvant Therapy in Breast Cancer
2023-01-09 | PXD032359 | Pride
Genomics Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
| PRJNA682420 | ENA
Transcriptomics Epigenetic regulation of NK cell-mediated immune response in multiple myeloma [RNA-Seq]
2024-01-23 | GSE228769 | GEO
Genomics Epigenetic regulation of NK cell-mediated immune response in multiple myeloma [ChIP-Seq]
2024-01-23 | GSE228768 | GEO